Roger himself has stated the following, and that time has arrived.
“In our view, the start and completion of the ‘first in man’ study of PPL1 will provide significant upside as it will open the doors for major cancer applications with large pharmaceutical companies. This should see our investors rewarded for helping us through the challenging early phase of the drug’s life.”
- Forums
- ASX - Day Trading
- Day Traders After Market Lounge 19th Feb
Roger himself has stated the following, and that time has...
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online